Trelegy Ellipta sales surged 16% during the quarter, owing to strong growth in all regions. Sales of Anoro Ellipta rose 6%. Key established drug Advair/Seretide sales rose 13%, while sales on ...

Robert F. Kennedy Jr. and other candidates for top health posts are at odds with the drug industry, setting the stage for tense battles over regulatory changes. By Rebecca Robbins Christina Jewett ...

As drug prices continue to rise and the affordability of medicines for patients remains out of reach, finding new and creative solutions that address affordability, while also rewarding innovation ...

Singulair binds to brain receptors affecting psychiatric functions Merck spinoff Organon confident in Singulair's safety profile FDA has no plan to update drug label based on new data Nov 22 ...

Since a schizophrenia drug, the first in decades with an innovative mechanism of action, gained US regulatory approval in September, some researchers have proclaimed a new era for psychiatric ...

Amanda Southcombe, GSK NZ General Manager, says funding for Trelegy Ellipta was recently announced, a single inhaler triple-therapy to treat the disease, which will see around 15,000 Kiwis ...

We need better utilisation of funding, more clinicians, and greater access to diagnostics,” he said. Amanda Southcombe, General Manager of GSK NZ, said recent funding for Trelegy Ellipta, a ...

Amanda Southcombe, GSK NZ General Manager, says funding for Trelegy Ellipta was recently announced, a single inhaler triple-therapy to treat the disease, which will see around 15,000 Kiwis suffering ...

One thing that makes several of them stand out is that drug use from their recent or distant past is not a major issue, is overshadowed by other issues or is not currently raising a furor in an ...